The sustained insider selling by an officer is a strong bearish signal. Monitor for upcoming earnings or pipeline updates that could trigger further downside.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 30 $67.50entry
- T+1 · 5mo ago −3.07%α −2.93% · $65.43
- T+5 · 4mo ago −7.69%α −8.29% · $62.31
- T+20 · 4mo ago −20.58%α −19.55% · $53.61
- T+60 · 8w ago −24.79%α −28.35% · $50.77
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Officer Dennis Mulroy filed a Form 144 to sell 9,476 shares (~$601K) of AnaptysBio, continuing a heavy selling pattern of over 300,000 shares in the past month. This persistent insider selling by a key officer is a bearish signal, suggesting potential negative catalysts ahead.
Key Facts
- Officer Dennis Mulroy intends to sell 9,476 shares of common stock, estimated value $601,213.35.
- Mulroy has sold over 300,000 shares in the past month (since May 15, 2026) across numerous transactions.
- The proposed sale follows a stock option exercise, resulting in dilution and insider cash-out.
- Filing date: June 29, 2026; broker: Morgan Stanley Smith Barney LLC.
Financial Impact
Proposed sale of $601K; cumulative insider selling in past month exceeds $15M based on transaction values listed.
Risk Factors
- Continued insider selling could pressure the stock price.
- Potential negative catalyst (e.g., clinical trial setback, guidance miss) may be imminent.
- High analyst bullishness (94% buy) contrasts with insider behavior, creating divergence risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006580 |
| Document: 0001950047-26-006580-index.html | 0001950047-26-006580 |
| Document: 0001950047-26-006580.txt | 0001950047-26-006580 |
Track record
28 reports on ANAB
9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
- Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
- Jun 29, 202620w ago 144 Bearish 6/10 Viewing Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
- Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
- Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
- Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers